sales@targetmol.com (US) / info@targetmol.com    Tel: (781) 999-4286 / (781) 999-5354
Home > JAK/STAT signaling > EGFR > CNX-2006
CNX-2006  
Catalog No. T6008    CAS 1375465-09-0
Pack Size
Availability
Price/USD
Quantity
2mg
In stock
66.00
5mg
In stock
113.00
10mg
In stock
195.00
25mg
In stock
333.00
50mg
In stock
488.00
100mg
Inquiry
878.00
1g
Get quote
0.00
5g
Get quote
0.00
1mg
In stock
46.00
200mg
Inquiry
1580.00
10 mM * 1 mL (in DMSO)
In stock
107.00
Bulk Size: Please Quote for Discount
Documents and Quality Management
Purity:99.16% COA Datasheet HNMR HPLC
Biological Activity:

Product Description:

CNX-2006 is a novel irreversible mutant-selective EGFR inhibitor with IC50 of < 20 nM, with very weak inhibition at wild-type EGFR.

Target:
mutant EGFR;
Research Area:
Cancer
Chemical Information:
Molecular Weight 545.53
Formula C26H27F4N7O2
CAS Number 1375465-09-0
Solubility DMSO:93 mg/mL (170.5 mM);Ethanol:28 mg/mL (51.3 mM);Water:<1 mg/mL
Storage 3 years -20°C powder;
2 years -80°C in solvent;
Remark For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ℃ for several month.
Technical Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store Products, and issues that need special attention for cell-based assays and animal experiments.

Related Compound Libraries
This product is contained In the following compound libraries:
  • The compound is not included in our libraries at this moment.
Product Recommendations
  • PD168393, PD168393 is an irreversible EGFR inhibitor (IC50: 0.70 nM), irreversibly alkylate Cys-773; inactive ...
  • Olmutinib (HM61713, BI 1482694), Olmutinib is an orally available small molecule, a mutant-selective inhibitor of epidermal growth fa...
  • NSC228155, NSC228155 is an activator of EGFR, binding to the sEGFR dimerization domain II and modulate EGFR tyr...
  • EAI045, EAI045, an allosteric inhibitor, targets towards drug-resistant EGFR mutants but avoids the wild-typ...
  • WZ3146, WZ3146 is a mutant-selective irreversible inhibitor of EGFR(L858R) and EGFR(E746_A750) with IC50 of ...

 

Reference

If you have additional questions, Please send us a message. * Required